H1N1 Flu Vaccine Availablity
Witnesses testified about production and distribution of the H1N1 swine flu vaccine to high-priority populations. They defended the… read more
Witnesses testified about production and distribution of the H1N1 swine flu vaccine to high-priority populations. They defended the distribution of swine flu vaccines against criticism that their plan to protect Americans was confusing and over-optimistic. Some committee members pressed for an apology and said they felt the Obama administration had not learned some valuable lessons from the continuing problem.
Manufacturers have delivered 48.5 million doses of H1N1 vaccine, but officials had hoped to have as many as 120 million doses. close
*The transcript for this program was compiled from uncorrected Closed Captioning.
People in this video
- Alexander Garza Chief Medical Officer Department of Homeland Security
- Thomas "Tom" R. Carper U.S. Senator [D] Delaware
- Susan M. Collins U.S. Senator [R] Maine
- Paul G. Kirk Jr. U.S. Senator [D] Massachusetts
- Joseph "Joe" Lieberman U.S. Senator [I] Connecticut
- Nicole Lurie Assistant Secretary Department of Health and Human Services->Preparedness and Response
- Claire McCaskill U.S. Senator [D] Missouri
- Anne Schuchat M.D. Director Centers for Disease Control and Prevention->National Ctr. for Immunization and Respir. Dis.
Two House Energy and Commerce Subcommittees held a joint hearing to examine the federal government’s preparedness…
Response to H1N1 Influenza Virus
The subcommittee met for an update on federal efforts to combat H1N1. They discussed the vaccine shortage, the…
Coordinating Federal Response to Swine Flu
Secretary Napolitano and Dr. Anne Schuchat testified about U.S. responses to H1N1 swine flu outbreak in Mexico and…
U.S. Bioterrorism Threats
Witnesses testified about bioterror threats and government policy and operations in responding to the threats. A…